Gyre Therapeutics, Inc. Share Price
GYRE$7.67
+$0.07 (0.92%) Last updated on 06 Sep, 2025 | 01:29 ISTGyre Therapeutics, Inc. Stock Performance
Open $7.88 | Prev. Close $7.60 | Circuit Range N/A |
Day Range $7.70 - $7.88 | Year Range $6.11 - $19.00 | Volume 3,088 |
Average Traded $7.75 |
Gyre Therapeutics, Inc. Share Price Chart
About Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Gyre Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Sep-25 | $7.88 | $7.70 | +1.25% |
04-Sep-25 | $7.88 | $7.60 | -6.39% |
03-Sep-25 | $7.45 | $8.12 | +4.96% |
02-Sep-25 | $7.86 | $7.74 | +0.00% |
29-Aug-25 | $8.12 | $7.74 | -6.47% |
28-Aug-25 | $8.04 | $8.27 | +1.86% |
27-Aug-25 | $8.25 | $8.12 | +4.36% |
FAQs on Gyre Therapeutics, Inc. Share Price
Can I buy Gyre Therapeutics, Inc. shares in India?
What is the share price of Gyre Therapeutics, Inc.?
What is the 5 year returns of Gyre Therapeutics, Inc.?
What are the high & low stock price of Gyre Therapeutics, Inc. today?
What is the 52-week high and low of Gyre Therapeutics, Inc. stock?